Skip to content

Clinical trials

Observational Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Phase: Observational Country / region: China Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20093
20106
20112
20124
20133
20143
20156
20164
201712
20189
201911
202012
202121
202215
202323
202431
202525
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status84
Recruiting63
Completed38
Not yet recruiting14
Enrolling by invitation5
Active, not recruiting4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital9
Changhai Hospital8
Chinese PLA General Hospital6
RenJi Hospital6
Second Affiliated Hospital, Zhejiang University, School of Medicine6
Xiangya Hospital of Central South University5
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine5
Anhui Provincial Hospital4
Chinese Academy of Medical Sciences, Fuwai Hospital4
Fudan University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease210
Lung Neoplasms18
Prostatic Neoplasms18
Stomach Neoplasms10
Pancreatic Neoplasms8
Neoplasms6
Sepsis6
Colorectal Neoplasms5
Hyperaldosteronism5
Hypertension, Pulmonary5

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.